Clinical Trials in Illinois

Showing 17321-17340 of 19,692 trials

Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade

NCT00945477

A growing body of literature supports the role of angiogenesis in the development and spread of a variety of human cancers including prostate cancer. * Vascular endothelial growth factor (VEGF) expression is low in normal prostate tissue, but markedly increased in tumor tissues, and has a positive association with tumor stage and grade * Plasma VEGF levels are significantly elevated in patients with hormone refractory prostate cancer (HRPC) compared to those patients with localized disease and have been associated with disease progression in other cancer patient population. * The Cancer and Leukemic Group-B demonstrated that VEGF levels correlate with survival. Pazopanib is a potent multi-target receptor tyrosine kinase inhibitor of vascular endothelial growth factor receptors.

Prostate Cancer

Illinois CancerCare, P.C.11 participantsStarted Jul 2009

Bloomington, Illinois, United States • Ottawa, Illinois, United States • Pekin, Illinois, United States +1 more locations

COMPLETEDPhase 1/235 miles

Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

NCT00002577

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients with non-small cell lung cancer that cannot be surgically removed.

Lung Cancer

Radiation Therapy Oncology Group36 participantsStarted Jul 1995

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Huntsville, Alabama, United States +239 more locations

Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade

Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Find Trials by Condition in Illinois

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus

S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors

Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome

Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)

The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol

A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)

Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression

Hernia Repair in Multiply Morbid Patients

Interferon-Alpha for Diabetes Mellitus Type 1

An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence

Evaluation of Radiographic and Patient Outcomes Following Lumbar Spine Fusion Using Demineralized Bone Matrix (DBM) Mixed With Autograft

Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus